https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062939/
Ghostwritten articles involve using planning companies whose job it is to design articles containing manipulated data to support a pharmaceutical product and then have these articles accepted by high-impact clinical journals, that is, the journals most likely to affect clinical decision making of doctors. Further, they supply doctors in clinical practice with free reprints of these manipulated articles

Only people mentioned by @Peacefull in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Alfredo Javegny, click on at the bottom under it